Your search for bevacizumab returned 72 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

News remove
Home remove

Your search for bevacizumab returned 72 results

Sort Results:

Relevant Recent
ASCO 2011

ICON7 Trial Shows Bevacizumab Increases Survival in Women with Newly Diagnosed Ovarian Cancer

The addition of bevacizumab to carboplatin and paclitaxel chemotherapy for the first-line treatment of women with ovarian cancer may offer benefit compared with standard chemotherapy alone, particularly for patients with more aggressive disease, investigators noted in a presentation during the American Society of Clinical Oncology's 2011 Annual Meeting.

ASCO: Continuing Avastin With 2nd-Line Chemo Ups Survival

Continuing use of bevacizumab (Avastin) in combination with second-line chemotherapy improves overall survival (OS) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC) who have progressed after discontinuation of first-line bevacizumab and chemotherapy.